Bimekizumab versus Adalimumab in Plaque Psoriasis

N Engl J Med. 2021 Sep 16;385(12):1149-1150. doi: 10.1056/NEJMc2113092.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adalimumab / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Humans
  • Psoriasis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • bimekizumab
  • Adalimumab